Oral Isotretinoin in The Treatment of Melasma A Randomized Controlled Clinical Trial
Melasma is a common refractory acquired hyperpigmentation of the skin having a serious impact on patients' quality of life. Melasma is challenging to treat. Treatment is often a multimodality approach. Due to the attached psychological and social stress, it is important to counsel patients with melasma adequately about the chronicity of the disease, the importance of photoprotection, and the role of hormones in disease persistence before embarking on therapeutic correction. So in this study, we are exploring the efficacy of oral isotretinoin for treating melasma.
• Age between 18 and 50 years
• Patients complaining of melasma.
• Patients with all types of melasma (epidermal, dermal and mixed)
• Sexually active women who is willing to follow at least 2 types of contraceptive methods during study period
• Patients with skin type I-V